Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024)
Roivant Sciences' (ROIV) quarterly Goodwill & Intangibles came in at $155.8 million in Q2 2024, little changed on a YoY basis from $155.3 million in Q3 2023, and little changed quarter-over-quarter from $155.2 million in Q1 2024.
Analysis
Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024) Analysis & Trends
Roivant Sciences (ROIV) has reported Goodwill & Intangibles for 3 consecutive years, with $155.8 million the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Goodwill & Intangibles changed 0.32% year-over-year to $155.8 million; the trailing twelve-month figure through Jun 2024 stood at $155.8 million (changed 0.32% YoY), and the FY2024 full-year result was $155.2 million, up 1.67% from the prior year.
- Goodwill & Intangibles held at $155.8 million in Q2 2024 per ROIV's latest filing, from $155.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $166.5 million in Q4 2023 and bottomed at $143.2 million in Q3 2022.
- Historically, Goodwill & Intangibles has averaged $153.2 million across 3 years, with a median of $153.1 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles increased 9.89% in 2023, then increased 0.32% in 2024.
- Over 3 years, Goodwill & Intangibles stood at $151.5 million in 2022, then grew by 9.89% to $166.5 million in 2023, then retreated by 6.42% to $155.8 million in 2024.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $155.8 million, $155.2 million, and $166.5 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.68 Bn | 197.69 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.84 Bn | 177.66 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.49 Bn | 56.31 Bn | 1.37 Bn |
| 6 | Moderna | 55.01 Bn | 49.87 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.08 Bn | 30.77 Bn | 992.69 Mn |
| 8 | Biogen | 31.35 Bn | 30.06 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn |
| 10 | Insmed | 27.84 Bn | 26.68 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 155.78 Mn |
| Mar 31, 2024 | 155.17 Mn |
| Dec 31, 2023 | 166.47 Mn |
| Sep 30, 2023 | 153.05 Mn |
| Jun 30, 2023 | 155.28 Mn |
| Mar 31, 2023 | 152.63 Mn |
| Dec 31, 2022 | 151.49 Mn |
| Sep 30, 2022 | 143.21 Mn |
| Jun 30, 2022 | 145.43 Mn |